Optimally preserved human tissue specimens are the backbone of cancer research for basic, clinical, translational and population scientists. The purpose of the Tissue Core (TC) is: 1. To ensure the collection and storage of well-annotated human tissues for research, and to provide investigators with access to high quality human specimens, including fresh and frozen tissues, fixed tissue, and DNA/RNA products. 2. To provide histology, immunohistochemistry and in-situ hybridization services for paraffin embedded tissue. These services, outsourced in the prior core submission, have been incorporated within the Moffitt Tissue Core Facility. 3. To manufacture tissue microarrays using our rich resource of archival material here at Moffitt Cancer Center. We have recently implemented a procedure for the transfer of all archival material no longer required for clinical care to the Tissue Core for research. These will provide a repository for the construction of tissue microarrays, a service that was also outsourced prior to this submission. The Core is administrated by Domenico Coppola, MD, and Mary E. Edgerton, MD, PhD, Scientific Directors, Tyron Hoover, MD, JD, Medical Director, and the Tissue Core Executive Committee (TCEC), a multidisciplinary committee responsible for recommending policy governing tissue release and utilization, and ensuring compliance with all appropriate regulatory bodies. On average, the Tissue Core has distributed over 1,000 tissue samples and nearly 800 nucleic acid derivatives per year to investigators. The Tissue Core (TC) future goals include implementation of standard tissue banking processes in a network of community hospitals, linking clinical outcomes to patient samples. In conjunction with the Informatics Core, TC is expanding its informatics support. There is also an ongoing effort to improve the collection, processing and storage of tissues, and to optimize the collection, processing and storage of fine needle aspirate specimens for molecular and proteomic analyses. Finally, TC is developing specialized tissue based molecular testing (FISH,C-ISH, gene polymorphism-Invader) as an adjunct to immunohistochemistry.

Agency
National Institute of Health (NIH)
Institute
National Cancer Institute (NCI)
Type
Center Core Grants (P30)
Project #
5P30CA076292-13
Application #
8214138
Study Section
Subcommittee G - Education (NCI)
Project Start
Project End
Budget Start
2011-02-01
Budget End
2012-01-31
Support Year
13
Fiscal Year
2011
Total Cost
$168,581
Indirect Cost
Name
H. Lee Moffitt Cancer Center & Research Institute
Department
Type
DUNS #
139301956
City
Tampa
State
FL
Country
United States
Zip Code
33612
Karolak, Aleksandra; Markov, Dmitry A; McCawley, Lisa J et al. (2018) Towards personalized computational oncology: from spatial models of tumour spheroids, to organoids, to tissues. J R Soc Interface 15:
Liu, Ying; Wang, Hua; Li, Qian et al. (2018) Radiologic Features of Small Pulmonary Nodules and Lung Cancer Risk in the National Lung Screening Trial: A Nested Case-Control Study. Radiology 286:298-306
Padron, Eric; Ball, Markus C; Teer, Jamie K et al. (2018) Germ line tissues for optimal detection of somatic variants in myelodysplastic syndromes. Blood 131:2402-2405
Verduzco, Daniel; Kuenzi, Brent M; Kinose, Fumi et al. (2018) Ceritinib Enhances the Efficacy of Trametinib in BRAF/NRAS-Wild-Type Melanoma Cell Lines. Mol Cancer Ther 17:73-83
Lee, Morgan S; Tyson, Dinorah Martinez; Gonzalez, Brian D et al. (2018) Anxiety and depression in Spanish-speaking Latina cancer patients prior to starting chemotherapy. Psychooncology 27:333-338
Correa, John B; Brandon, Karen O; Meltzer, Lauren R et al. (2018) Electronic cigarette use among patients with cancer: Reasons for use, beliefs, and patient-provider communication. Psychooncology 27:1757-1764
Divakaran, Anand; Talluri, Siva K; Ayoub, Alex M et al. (2018) Molecular Basis for the N-Terminal Bromodomain-and-Extra-Terminal-Family Selectivity of a Dual Kinase-Bromodomain Inhibitor. J Med Chem 61:9316-9334
de Mingo Pulido, Álvaro; Gardner, Alycia; Hiebler, Shandi et al. (2018) TIM-3 Regulates CD103+ Dendritic Cell Function and Response to Chemotherapy in Breast Cancer. Cancer Cell 33:60-74.e6
Li, Gongbo; Boucher, Justin C; Kotani, Hiroshi et al. (2018) 4-1BB enhancement of CAR T function requires NF-?B and TRAFs. JCI Insight 3:
McIntyre, Jessica; Jiménez, Julio; Rivera, Yonaira M et al. (2018) Comparison of Health Communication Channels for Reaching Hispanics About Biobanking: a Pilot Trial. J Cancer Educ 33:833-841

Showing the most recent 10 out of 1254 publications